S. Kelly
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research 6
- Rheumatoid Arthritis Research and Therapies 5
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 2
-
- Monoclonal and Polyclonal Antibodies Research 4
- Hematology top 10%
-
- Chronic Lymphocytic Leukemia Research 1
-
- Lymphoma Diagnosis and Treatment 3
-
- Chemokine receptors and signaling 2
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Sylvia MitchellIan LockhartPeter NashRené WesthovensAndrew ChalmersLeonard H. SigalRubén Burgos‐VargasDavid D’Cruz
- Journals
- Annals of the Rheumatic Diseases (6 papers)Clinical and Experimental Rheumatology (1 paper)Dementia and Geriatric Cognitive Disorders (1 paper)
- Partner nations
- United StatesSwedenUnited Kingdom
In The Last Decade
S. Kelly
12 papers receiving 518 citations
Peers
Comparison fields: 5 of 74
- Rheumatology 351
- Immunology 225
- Radiology, Nuclear Medicine and Imaging 160
- Hematology 76
- Genetics 49
Countries citing papers authored by S. Kelly
This map shows the geographic impact of S. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Kelly more than expected).
Fields of papers citing papers by S. Kelly
This network shows the impact of papers produced by S. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Kelly. The network helps show where S. Kelly may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Kelly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2017 | 2 | |
| 3 | De-Convolution of Whole Blood Transcriptomic Data From a Phase Jib, Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept in Systemic Lupus Erythematosus | 2016 | 1 |
| 4 | 2016 | 4 | |
| 5 | 2016 | 2 | |
| 6 | De-Convolution of Whole Blood Transcriptomic Data from a Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept in Systemic Lupus Erythematosus | 2015 | 1 |
| 7 | 2013 | 2 | |
| 8 | 2010 | 274 | |
| 9 | 2009 | 77 | |
| 10 | The Efficacy and Safety of Abatacept in SLE: Results of a 12-month Exploratory Study | 2008 | 15 |
| 11 | 2008 | 123 | |
| 12 | 1996 | 39 |
About S. Kelly
S. Kelly is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 12 papers that have together received 541 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Chemokine receptors and signaling (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Rheumatology (351 citations), Immunology (225 citations) and Radiology, Nuclear Medicine and Imaging (160 citations). S. Kelly has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Sylvia Mitchell, Ian Lockhart, Peter Nash, René Westhovens, Andrew Chalmers, Leonard H. Sigal, Rubén Burgos‐Vargas, David D’Cruz, Sang‐Cheol Bae and Kartik Raghupathi. Their work appears in journals such as Annals of the Rheumatic Diseases, Clinical and Experimental Rheumatology, Dementia and Geriatric Cognitive Disorders, Queensland's institutional digital repository (The University of Queensland) and Arthritis & Rheumatism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.